A comparative study of cefixime and chloramphenicol in children with typhoid fever

Journal of the Pakistan Medical Association

Volumn 48, Issue 6, 1998, Pages 163-164

  Rabbani, M Waqar ^a   Iqbal, Imran ^a   Malik, M Suleman ^a  

^a NISHTAR MEDICAL COLLEGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFIXIME; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; DRUG DERIVATIVE;

ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REMISSION; SAFETY; TIME; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; CEFIXIME; CEFOTAXIME; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CHLORAMPHENICOL; FEMALE; HUMANS; MALE; REMISSION INDUCTION; SAFETY; TIME FACTORS; TYPHOID FEVER;

EID: 0032091060     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Rev. Infect. dis. 1986;8:329-349.
2. Vazquez V, Caleron E Rodriguez RS. Chloramphenicol resistant strains of Salmonella typhosa N. Engl. J. Med, 1972;286:1220.
3. Rowe B, Ward LR, Threlfall EJ. Treatment of multiresistant typhoid fever. Lancet, 1991;337:1422.
4. Arora RK, Gupta A, Joshi NM et al. Multidrug resistant typhoid fever: Study of an outbreak in Calcutta, India. Indian Paediatr., 1992;29:61-66.
5. Bhutta ZA, Naqvi SH, Razzaq, RA et al. Multidrug resistant typhoid in children. Presentation and clinical features. Rev. Infect. Dis, 1991;13:832-836.
6. Smith SM, Palumbo PE, Edelson PJ. Salmonella strains resistant to multiple antibiotics. Therapeutic implications. Pediatr. Infect. Dis., 1984;3:455-460.
7. Mourad AS, Metwally M, Mour EL et al. Multidrug resistant salmonella typhi. Clin. Infect. Dis, 1993;17:135.
8. Biyan JP, Rocha H, Sched WM. Problems in salmonellosis: rationale for clinical trials with newer Blactam agents and quinolones. Rev. Infect. Dis., 1986;8:189-207.
9. Karande SC, Kshirsagar NA. Adverse drug reactions: Monitoring of ciprofloxacin in Pediatric Practice. Indian Pediatr., 1992;29:181-87.
10. Bavdekar A, Chaudhari M, Bhave S et al. Ciprofloxacin in typhoid fever. Indian J. Pediatr, 1991;58:335-339.
11. Naqvi SH, Bhutta ZA, Farooqui BH. Therapy of multidrug resistant typhoid in 58 children. Scand. J. Infect. Dis. 1992;24:175-179.
12. Lasserre R, Sangalang RP, Santiag L. Three day treatment of typhoid fever with two different doses of ceftriaxone, compered to 14 days therapy with chloramphenicol: A randomized trial. J. Antimicrob., Chemother., 1991;28:765-772.
13. Soe GB, Overturf GD. Treatment of typhoid fever and other systemic salmonellosis with cefotaxime, ceftriaxone, cefoparazone and other newer cephalosporins. Rev Infect. Dis., 1987;9:719-736
14. Gulati S, Morwah RL, Singhi S et al. Third generation cephalosporins in multidrug resistant typhoid fever. Indian Pediatr., 1992;29:513-516.
15. Nev HC. In vitro activity of a new broad spectrum, betalactamase stable oral cephalosporin, cefixime, J. Pediatr Infect. Dis., 1987;6:963-970.
16. Girgis NI, Kilpatrick ME, Farid Z et al. Cefixime in the treatment of enteric fever in children. Drug Exp. Clin. Res., 1993;19:47-49.
17. Bhutta ZA, Khan IA, Molla AM. Therapy of multidrug resistant typhoid fever with oral Cefixime VS intravenous ceftriaxone. Pediatr. Infect. Dis. J., 1994;13:990-994.